Kisspeptin-10 vs Kisspeptin-54
Written by Aaron CuhaReviewed Sep 2026
The short answer
Two lengths of the same peptide with very different evidence. Kisspeptin-54 has truly good trial data, all of it about ripening eggs for IVF. In 60 women at high risk of a dangerous over response to IVF drugs, it ripened eggs in 95 percent of them, with no moderate, severe or critical cases of over response.
- Kisspeptin-10 people
- 44
- Kisspeptin-10 nulls
- 1
- Kisspeptin-54 people
- 122
- Kisspeptin-54 nulls
- 1
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
4 completed trials, 44 people given it
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
5 completed trials, 122 people given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
Kisspeptin-10Kisspeptin-10
A piece of a brain hormone that makes the body release its own GnRH. It is studied for fertility, low sex hormones and sexual response.
Column B
Kisspeptin-54Kisspeptin-54, the 54 residue KISS1 gene product
Good human studies, all about ripening eggs for IVF. In 60 women at high risk of dangerous ovary swelling, eggs ripened in 95%, and nobody got moderate or worse swelling. Given over and over, it stops working. A controlled study found it did nothing for anxiety. In adult male rats, long-term shots damaged the testes.
Side by side, on the facts we can check
| What we compare | Kisspeptin-10 | Kisspeptin-54 |
|---|---|---|
| Category | Hormone | Hormone |
| FDA status | Investigational, not FDA-approved | Investigational. No approved kisspeptin product exists in any country. The work using it to trigger egg release in IVF is still in mid-stage studies. It has not moved on to the final-stage studies that could lead to approval. |
| Half-life | Short (minutes) | No human pharmacokinetic curve is asserted here because none was resolved in this pass. What the trials report instead is the downstream effect: a single subcutaneous dose produces a luteinising hormone surge the investigators describe as lasting roughly half a day, which is a pharmacodynamic duration and not a plasma half-life. |
| Molecular weight | ~1,302 Da | A 54 residue peptide, roughly 6 kDa. |
| How it works | It switches on kisspeptin receptors on the brain cells that make GnRH. Those cells then release the body's own GnRH, which drives the other sex hormones. | Shown in people, not just guessed. Kisspeptin-54 locks onto a receptor called KISS1R on the brain cells that release GnRH, the master switch for sex hormones. That makes the pituitary gland release LH and FSH, the two hormones that drive the ovaries and testes. The LH rise has been measured in people after a shot under the skin, a drip into a vein, and a nasal spray. One shot under the skin gives an LH surge the researchers say lasts about half a day. Keep the receptor switched on all the time and it goes numb. That is why regular dosing makes the effect fade instead of lasting. |
| Studies in people | 8 | 5 |
| Evidence | Limited: 4 completed trials, 44 people given it | Moderate: 5 completed trials, 122 people given it |
| Legal status, US | Investigational, not approved | Investigational, not approved |
Frequently asked questions
What is the difference between Kisspeptin-10 and Kisspeptin-54?
Kisspeptin-10: A piece of a brain hormone that makes the body release its own GnRH. It is studied for fertility, low sex hormones and sexual response. Kisspeptin-54: Good human studies, all about ripening eggs for IVF. In 60 women at high risk of dangerous ovary swelling, eggs ripened in 95%, and nobody got moderate or worse swelling. Given over and over, it stops working. A controlled study found it did nothing for anxiety. In adult male rats, long-term shots damaged the testes.
Which has stronger research evidence, Kisspeptin-10 or Kisspeptin-54?
Each compound gets a band worked out from facts we counted, with the math shown. Kisspeptin-10 is Limited (4 completed trials, 44 people given it). Kisspeptin-54 is Moderate (5 completed trials, 122 people given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are Kisspeptin-10 and Kisspeptin-54 FDA-approved?
Kisspeptin-10: Investigational, not FDA-approved. Kisspeptin-54: Investigational. No approved kisspeptin product exists in any country. The work using it to trigger egg release in IVF is still in mid-stage studies. It has not moved on to the final-stage studies that could lead to approval..
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.